Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "TILT[LastUpdatePostDate]SEARCH[Study]AREA[SponsorSearch]Fuda Cancer Hospital, Guangzhou"
Count: 116
Selected: 0
NCT IDTitle
NCT03180437Safety and Efficiency of IRE Plus γδ T Cell Against Locally Advanced Pancreatic Cancer
NCT03985462Very Small Embryonic-like Stem Cells for Ovary
NCT03976206Very Small Embryonic-like Stem Cells for Facial Skin Antiaging
NCT03975101Very Small Embryonic-like Stem Cells for Knee Osteoarthritis
NCT03973021Very Small Embryonic-like Stem Cells for Erectile Dysfunction
NCT03183232Safety and Efficiency of γδ T Cell Against Lung Cancer
NCT03183219Safety and Efficiency of γδ T Cell Against Liver Cancer
NCT03183206Safety and Efficiency of γδ T Cell Against Breast Cancer
NCT03357315Mix Vaccine for Metastatic Sarcoma Patients
NCT03357289Mix Vaccine for Metastatic Kidney Cancer
NCT03357276Mix Vaccine for Metastatic Colorectal Cancer
NCT02425748Safety and Efficiency of γδ T Cell Against Non Small Lung Cancer ( Without EGFR Mutation)
NCT02449135Nano Drug Interventional Therapy Using Digital Subtraction Angiography(DSA) for Pancreatic Carcinoma
NCT04393220Combination of PD-1 and VEGFR-2 Blockade for Advanced Hepatocellular Carcinoma
NCT03673137Phase II/III of Randomized Controlled Clinical Research on IRE Synchronous Chemotherapy for LAPC
NCT02430779Irreversible Electroporation(IRE) For Unresectable Renal Pelvic and Ureteral Neoplasms
NCT02430766Irreversible Electroporation(IRE) For Unresectable Lymph Node Metastases(Close to Nerve)
NCT02430753Irreversible Electroporation(IRE) For Lung Neoplasms Accompanied by Respiratory Function Insufficiency
NCT02430701Irreversible Electroporation(IRE) For Unresectable Esophageal Neoplasms
NCT02430688Irreversible Electroporation(IRE) For Unresectable Extremities Neoplasms
NCT02430675Irreversible Electroporation(IRE) For Unresectable Laryngeal Neoplasms
NCT02430662Irreversible Electroporation(IRE) For Unresectable Gallbladder Neoplasms
NCT02430636Irreversible Electroporation(IRE) For Unresectable Stomach Neoplasms
NCT02430623Irreversible Electroporation(IRE) For Unresectable Urinary Bladder Neoplasms
NCT02430610Irreversible Electroporation(IRE) For Uterine Cervical Neoplasms
NCT02430597Irreversible Electroporation(IRE) For Unresectable Hilus Pulmonis Neoplasms
NCT02425059Irreversible Electroporation(IRE) For Unresectable Rectal Neoplasms
NCT02352935Percutaneous Irreversible Electroporation for Unresectable Hepatic Carcinoma in Poor Liver Function
NCT02343835Anti-Tumor Immunity Induced by IRE of Unresectable Pancreatic Cancer
NCT02340858Percutaneous Irreversible Electroportion for Unresectable Breast Cancer
NCT02335827Irreversible Electroporation(IRE) For Unresectable Renal Tumors
NCT02335112Irreversible Electroporation(IRE) For Unresectable Head and Neck Neoplasms
NCT02333773Irreversible Electroporation(IRE) For Unresectable Portal Venous Tumor Emboli
NCT02332551Percutaneous Irreversible Electroporation to Treat Liver Cancer Close to the Gallbladder
NCT02329106Percutaneous Irreversible Electroportion in Unresectable Liver Cancer Close to Diaphragmatic Dome
NCT02981719Simultaneous Gemcitabine and Irreversible Electroporation for Locally Advanced Pancreatic Cancer
NCT03818347Hydrogen Gas for Cancer Rehabilitation
NCT03554395Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Gastric Cancer
NCT03540199Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Kidney Cancer
NCT03524274Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Colorectal Cancer
NCT03524261Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Breast Cancer
NCT03509298Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Pancreatic Cancer
NCT03501056Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Lung Cancer
NCT03484962Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Liver Cancer
NCT02857920Combination of Bevacizumab and Allogeneic NK Immunotherapy for Metastatic Solid Tumors
NCT04406610CAR-T Cell Immunotherapy for GD2 Positive Glioma Patients
NCT03252171CAR-T Cell Immunotherapy for GD2 Positive Glioma Patients
NCT02723942CAR-T Cell Immunotherapy for HCC Targeting GPC3
NCT02575261CAR-T Cell Immunotherapy for EphA2 Positive Malignant Glioma Patients
NCT02547961Chimeric Antigen Receptor-Modified T Cells for Breast Cancer